HK 054 V
Alternative Names: HK-054-VLatest Information Update: 18 Sep 2023
At a glance
- Originator Hefei HankeMab Biotechnology
- Class Antineoplastics; Immunotherapies; Interleukins; Recombinant fusion proteins
- Mechanism of Action Interferon gamma stimulants; Interleukin 12 stimulants; Natural killer cell stimulants; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours